Search

everythinglearnresearchcommunity

for

Search:↓

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Combining oral minoxidil and bicalutamide may help improve hair growth in adolescent girls.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

The compound 4c showed strong potential as an anticancer agent.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

Ovarian function was similar in both treatment groups, but both caused excessive hair growth.

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

Bicalutamide is more effective and safer than spironolactone for treating female hair loss.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

17-β estradiol and prednisolone may speed up hair regrowth after chemotherapy.

Topical corticosteroids can cause serious side effects like Cushing's syndrome and hirsutism.

Costunolide helps human hair cells grow and can stimulate hair growth in mice.